Lung cancer radiation study pulled before it even started
NCT ID NCT05488626
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if a newer, daily-adaptive radiation technique could reduce coughing, breathing trouble, and swallowing pain in people with stage III non-small cell lung cancer getting chemo and radiation. It planned to compare the adaptive method to standard radiation. However, the trial was withdrawn before enrolling any participants, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE III NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Glowing drug reveals why lung cancer immunotherapy fails
- Gene-Hacked immune cells take on tough cancers
- Thymus gland may hold key to preventing immune cell loss during lung cancer treatment
- New combo therapy shows promise for tough lung cancer
- New lung cancer combo aims to boost treatment completion
- Blood test may personalize lung cancer therapy